Clarkston Capital Partners LLC decreased its holdings in Envista Holdings Corporation (NYSE:NVST – Free Report) by 8.2% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,317,255 shares of the company’s stock after selling 386,075 shares during the quarter. Envista comprises approximately 1.9% of Clarkston Capital Partners LLC’s portfolio, making the stock its 17th biggest holding. Clarkston Capital Partners LLC owned about 2.63% of Envista worth $87,942,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently bought and sold shares of NVST. Farther Finance Advisors LLC boosted its stake in Envista by 317.6% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock worth $27,000 after buying an additional 1,026 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Envista by 73.1% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after acquiring an additional 949 shares during the last quarter. EverSource Wealth Advisors LLC increased its stake in shares of Envista by 378.0% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock valued at $47,000 after acquiring an additional 1,909 shares during the last quarter. SJS Investment Consulting Inc. lifted its holdings in shares of Envista by 10,356.5% during the 3rd quarter. SJS Investment Consulting Inc. now owns 2,405 shares of the company’s stock worth $49,000 after acquiring an additional 2,382 shares during the period. Finally, GAMMA Investing LLC lifted its holdings in shares of Envista by 34.3% during the 3rd quarter. GAMMA Investing LLC now owns 2,498 shares of the company’s stock worth $51,000 after acquiring an additional 638 shares during the period.
Analyst Ratings Changes
Several equities analysts have recently weighed in on NVST shares. Morgan Stanley set a $19.00 price objective on Envista in a research note on Friday, February 6th. Wells Fargo & Company raised their price target on shares of Envista from $21.00 to $26.00 and gave the company an “equal weight” rating in a report on Friday, February 6th. Piper Sandler reaffirmed a “neutral” rating and set a $25.00 price target (up from $21.00) on shares of Envista in a research report on Friday, February 6th. Barclays boosted their price objective on shares of Envista from $24.00 to $34.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 11th. Finally, Mizuho increased their price objective on shares of Envista from $24.00 to $27.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 10th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $27.75.
Insiders Place Their Bets
In other news, SVP Mischa Reis sold 9,675 shares of the stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total transaction of $290,250.00. Following the sale, the senior vice president directly owned 32,382 shares in the company, valued at approximately $971,460. This represents a 23.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.66% of the stock is currently owned by company insiders.
Envista Price Performance
NVST stock opened at $26.82 on Monday. The stock’s 50 day moving average is $25.79 and its two-hundred day moving average is $22.44. Envista Holdings Corporation has a 52-week low of $14.22 and a 52-week high of $30.42. The company has a market capitalization of $4.40 billion, a PE ratio of 95.79, a P/E/G ratio of 1.83 and a beta of 0.95. The company has a quick ratio of 2.04, a current ratio of 2.38 and a debt-to-equity ratio of 0.47.
Envista (NYSE:NVST – Get Free Report) last released its earnings results on Thursday, February 5th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.32 by $0.06. Envista had a net margin of 1.73% and a return on equity of 6.54%. During the same period in the prior year, the company posted $0.24 earnings per share. Envista’s revenue was up 15.0% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Analysts predict that Envista Holdings Corporation will post 1 earnings per share for the current fiscal year.
Envista Profile
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
See Also
- Five stocks we like better than Envista
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
